SRF/SSR Virendra Mahesh New Investigator (USA): The AMH/AMHR2 axis as a target for contraception
Dr David Pépin, Associate Professor, Massachusetts General Hospital, Harvard Medical School, USA
Dr. Pépin is an Associate Professor in the Department of Surgery at Harvard Medical School, an Associate Molecular Biologist at the Massachusetts General Hospital, and the Associate Director of the Pediatric Surgical Research Laboratories of the Massachusetts General Hospital.
Dr. Pépin trained as a reproductive biologist, completing his Ph.D. at the University of Ottawa, Canada, studying the role of SMARCA1 in the regulation of ovarian folliculogenesis under the mentorship of Barbara C. Vanderhyden. Dr. Pépin then pursued his postdoctoral training in the laboratory of Patricia K. Donahoe, at the Massachusetts General Hospital in Boston, where he worked on the biology of Mullerian Inhibiting Substance (MIS or AMH) and its application to the treatment of ovarian cancer.
Dr. Pépin now leads a laboratory investigating the role of AMH/MIS in female reproduction and particularly in the context of ovarian function and diseases. His research includes basic reproductive development, and applied translational work in contraception, oncofertility, assisted reproduction, and ovarian cancer.